Alteration of mineral crystallinity and collagen cross-linking of bones in osteopetrotic toothless (tl/tl) rats and their improvement after treatment with colony stimulating factor-1.
A common feature of various types of mammalian osteopetroses is a marked increase in bone mass accompanied by spontaneous bone fractures. The toothless (tl/tl) rat osteopetrotic mutation is characterized by drastically reduced bone resorption due to a profound deficiency of osteoclasts and their precursors. An altered bone morphology has also been observed. The mutants cannot be cured by bone marrow transplantation, but skeletal defects are greatly reduced after treatment with colony stimulating factor 1 (CSF-1). The objectives of this study were to characterize mineral and collagen matrices in cancellous and compact bone isolated from long bones of 6-week-old normal littermates, tl/tl osteopetrotic mutants and mutants (tl/tl) treated with CSF-1. There were no differences in bone mineral content, but a significant decrease in the crystallinity of mineral evaluated by the method based on electron paramagnetic resonance spectrometry was observed in all bones of tl/tl mutants as compared to that of controls. Within the collagen matrix, slight decreases in the labile cross-links, but significant increases in the content of the stable cross-links, pyridinoline, and deoxypyridinoline, were observed in both cancellous and compact bone of osteopetrotic mutants. In tl/tl mutants treated with human recombinant CSF-1, the normalization of the crystallinity of bone mineral as well as collagen cross-links was found. Our results indicate that remodeling of bone matrix in tl/tl mutants is highly suppressed, but that after treatment with CSF-1, this activity recovers significantly. Taken together, these data provide further support for the hypothesis that CSF-1 is an essential factor for normal osteoclast differentiation and bone remodelling.
Wojtowicz
A
A
Dental Research Center, University of North Carolina, Chapel Hill 27599-7455, USA.
Dziedzic-Goclawska
A
A
Kaminski
A
A
Stachowicz
W
W
Wojtowicz
K
K
Marks
S C
SC
Yamauchi
M
M
D000818:Animals; D015519:Bone Density / Q000187:drug effects*; D003094:Collagen / Q000737:chemistry*; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D003460:Crystallization; D004578:Electron Spin Resonance Spectroscopy; D006801:Humans; D046911:Macromolecular Substances; D016173:Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D010022:Osteopetrosis / Q000188:drug therapy*; D051381:Rats; D011922:Rats, Mutant Strains; D011994:Recombinant Proteins; D014071:Tooth Abnormalities / Q000503:physiopathology
D003115:Colony-Stimulating Factors; D046911:Macromolecular Substances; D011994:Recombinant Proteins; D016173:Macrophage Colony-Stimulating Factor; D003094:Collagen